| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | Mar 13, 2024 | Sale | $28.33 | 723 | 20,483 | 77,692 | Mar 15, 2024, 04:45 PM | |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | Mar 04, 2024 | Sale | $24.72 | 41,292 | 1,020,851 | 99,061 | Mar 06, 2024, 08:13 PM | |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | Dec 14, 2023 | Sale | $20.76 | 597 | 12,394 | 77,910 | Dec 18, 2023, 08:49 PM | |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | Sep 21, 2023 | Sale | $27.22 | 10,000 | 272,156 | 51,010 | Sep 25, 2023, 08:31 PM | |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | Sep 13, 2023 | Sale | $50.34 | 617 | 31,060 | 46,010 | Sep 25, 2023, 08:31 PM | |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | Aug 28, 2023 | Sale | $28.17 | 11,490 | 323,729 | 52,372 | Aug 30, 2023, 07:04 PM | |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | Jun 21, 2023 | Sale | $52.26 | 11,349 | 593,095 | 68,627 | Jun 23, 2023, 08:06 PM | |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | Jun 22, 2023 | Sale | $52.18 | 11,000 | 573,935 | 57,627 | Jun 23, 2023, 08:06 PM | |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | Jun 23, 2023 | Sale | $50.76 | 11,000 | 558,360 | 47,127 | Jun 23, 2023, 08:06 PM | |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | Jun 13, 2023 | Sale | $55.16 | 591 | 32,600 | 79,976 | Jun 15, 2023, 09:29 PM | |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | Mar 10, 2023 | Option Exercise | $43.46 | 701 | 30,465 | 80,567 | Mar 14, 2023, 04:20 PM | |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | Jan 13, 2023 | Sale | $50.53 | 5,000 | 252,651 | 85,220 | Jan 18, 2023, 05:30 PM | |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | Dec 12, 2022 | Sale | $43.23 | 5,000 | 216,137 | 86,670 | Dec 13, 2022, 08:24 PM | |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | Nov 10, 2022 | Sale | $39.42 | 5,000 | 197,105 | 72,173 | Nov 14, 2022, 05:26 PM | |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | Oct 10, 2022 | Sale | $37.99 | 5,000 | 189,950 | 77,073 | Oct 12, 2022, 04:59 PM | |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | Sep 13, 2022 | Sale | $27.48 | 40,000 | 1,099,228 | 96,059 | Sep 15, 2022, 07:59 PM | |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | Jun 30, 2022 | Option Exercise | $8.03 | 1,152 | 9,251 | 122,073 | Sep 13, 2022, 09:15 PM | |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | Oct 15, 2021 | Sale | $21.59 | 12,500 | 269,826 | 121,021 | Oct 18, 2021, 04:21 PM | |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | Sep 15, 2021 | Sale | $24.69 | 12,500 | 308,605 | 135,421 | Sep 17, 2021, 04:05 PM | |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | Aug 16, 2021 | Sale | $18.79 | 10,000 | 187,900 | 145,921 | Aug 17, 2021, 09:15 PM | |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | Jul 15, 2021 | Sale | $20.90 | 10,000 | 209,044 | 155,921 | Jul 19, 2021, 04:43 PM | |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | Jun 30, 2020 | Option Exercise | $17.07 | 1,245 | 21,250 | 164,914 | Dec 09, 2020, 08:50 PM | |
| AKRO | Akero Therapeutics, Inc. | Yale Catriona | Chief Development Officer | Dec 31, 2019 | Option Exercise | $18.87 | 1,025 | 19,338 | 163,669 | Jan 03, 2020, 06:16 PM |
Menu